BR112015026484A2 - tratamento ou prevenção de dano neuronal não inflamatório de trauma cerebral e acidentes vasculares cerebrais usando mentol, linalool e/ou icilin - Google Patents
tratamento ou prevenção de dano neuronal não inflamatório de trauma cerebral e acidentes vasculares cerebrais usando mentol, linalool e/ou icilinInfo
- Publication number
- BR112015026484A2 BR112015026484A2 BR112015026484A BR112015026484A BR112015026484A2 BR 112015026484 A2 BR112015026484 A2 BR 112015026484A2 BR 112015026484 A BR112015026484 A BR 112015026484A BR 112015026484 A BR112015026484 A BR 112015026484A BR 112015026484 A2 BR112015026484 A2 BR 112015026484A2
- Authority
- BR
- Brazil
- Prior art keywords
- icilin
- linalool
- menthol
- neuronal damage
- brain trauma
- Prior art date
Links
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 title abstract 6
- 208000030886 Traumatic Brain injury Diseases 0.000 title abstract 4
- 230000003961 neuronal insult Effects 0.000 title abstract 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 title abstract 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 title abstract 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 title abstract 3
- RCEFMOGVOYEGJN-UHFFFAOYSA-N 3-(2-hydroxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one Chemical compound OC1=CC=CC=C1N1C(=O)NC(C=2C=C(C=CC=2)[N+]([O-])=O)=CC1 RCEFMOGVOYEGJN-UHFFFAOYSA-N 0.000 title abstract 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 title abstract 3
- 229930007744 linalool Natural products 0.000 title abstract 3
- 229940041616 menthol Drugs 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361827232P | 2013-05-24 | 2013-05-24 | |
| PCT/EP2014/060637 WO2014187945A1 (en) | 2013-05-24 | 2014-05-23 | Treatment or prevention of non-inflammatory neuronal damage from brain trauma and strokes using menthol, linalool and/or icilin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015026484A2 true BR112015026484A2 (pt) | 2017-07-25 |
Family
ID=50819728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015026484A BR112015026484A2 (pt) | 2013-05-24 | 2014-05-23 | tratamento ou prevenção de dano neuronal não inflamatório de trauma cerebral e acidentes vasculares cerebrais usando mentol, linalool e/ou icilin |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20160166570A1 (enExample) |
| EP (1) | EP3003292B1 (enExample) |
| JP (2) | JP2016520588A (enExample) |
| CN (1) | CN105228601A (enExample) |
| AU (2) | AU2014270341A1 (enExample) |
| BR (1) | BR112015026484A2 (enExample) |
| CA (1) | CA2908365C (enExample) |
| ES (1) | ES2721922T3 (enExample) |
| TR (1) | TR201906539T4 (enExample) |
| WO (1) | WO2014187945A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160166570A1 (en) * | 2013-05-24 | 2016-06-16 | Nestec S.A. | Treatment or prevention of non-inflammatory neuronal damage from brain trauma and strokes using menthol, linalool and/or icilin |
| WO2021189256A1 (zh) * | 2020-03-24 | 2021-09-30 | 中国医药大学 | 薄荷醇用于制备治疗神经退化症及中风的外用组合物的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2483635A1 (en) * | 2002-04-25 | 2003-11-06 | Alon Shalev | Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head |
| JP4742204B2 (ja) * | 2005-01-21 | 2011-08-10 | 財団法人ヒューマンサイエンス振興財団 | 脂肪細胞分化制御剤 |
| JP2007291069A (ja) * | 2006-03-31 | 2007-11-08 | Daiichi Sankyo Healthcare Co Ltd | 抗酸化剤および／または消炎鎮痛剤組成物 |
| GB0615136D0 (en) * | 2006-07-29 | 2006-09-06 | Univ Edinburgh | Induction of analgesia in neuropathic pain |
| KR20090085237A (ko) * | 2008-02-04 | 2009-08-07 | 김병문 | 천연 진주가루를 함유한 뇌질환 예방 및 치료용 한약조성물 |
| EP3485881B1 (en) * | 2009-07-10 | 2024-03-13 | President and Fellows of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
| KR20120103317A (ko) * | 2011-03-10 | 2012-09-19 | 한국생명공학연구원 | 아실 코에이:콜레스테롤 아실트랜스퍼라제 저해활성을 갖는 고수씨 추출물 또는 이로부터 분리된 리나로올을 포함하는 조성물 |
| AU2012357747B2 (en) * | 2011-12-19 | 2017-09-07 | Dompe' Farmaceutici S.P.A. | TRPM8 antagonists |
| CN102512634A (zh) * | 2011-12-26 | 2012-06-27 | 神威药业（张家口）有限公司 | 复方麝香软胶囊及其制备方法 |
| WO2013168090A1 (en) * | 2012-05-07 | 2013-11-14 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Researc Organization (Aro) (Volcanii Center). | Geranium oil and constituents thereof for treatment of neurodegenerative diseases |
| US20160166570A1 (en) * | 2013-05-24 | 2016-06-16 | Nestec S.A. | Treatment or prevention of non-inflammatory neuronal damage from brain trauma and strokes using menthol, linalool and/or icilin |
-
2014
- 2014-05-23 US US14/892,287 patent/US20160166570A1/en not_active Abandoned
- 2014-05-23 ES ES14726347T patent/ES2721922T3/es active Active
- 2014-05-23 BR BR112015026484A patent/BR112015026484A2/pt not_active Application Discontinuation
- 2014-05-23 EP EP14726347.9A patent/EP3003292B1/en active Active
- 2014-05-23 WO PCT/EP2014/060637 patent/WO2014187945A1/en not_active Ceased
- 2014-05-23 CN CN201480029057.2A patent/CN105228601A/zh active Pending
- 2014-05-23 JP JP2016514431A patent/JP2016520588A/ja not_active Withdrawn
- 2014-05-23 CA CA2908365A patent/CA2908365C/en active Active
- 2014-05-23 AU AU2014270341A patent/AU2014270341A1/en not_active Abandoned
- 2014-05-23 TR TR2019/06539T patent/TR201906539T4/tr unknown
-
2017
- 2017-03-17 US US15/462,387 patent/US10799502B2/en active Active
-
2019
- 2019-08-26 AU AU2019222781A patent/AU2019222781B2/en active Active
- 2019-09-26 JP JP2019175366A patent/JP2020011985A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016520588A (ja) | 2016-07-14 |
| US10799502B2 (en) | 2020-10-13 |
| CN105228601A (zh) | 2016-01-06 |
| EP3003292A1 (en) | 2016-04-13 |
| US20170189403A1 (en) | 2017-07-06 |
| TR201906539T4 (tr) | 2019-05-21 |
| JP2020011985A (ja) | 2020-01-23 |
| AU2014270341A1 (en) | 2015-10-08 |
| US20160166570A1 (en) | 2016-06-16 |
| AU2019222781A1 (en) | 2019-09-12 |
| CA2908365A1 (en) | 2014-11-27 |
| AU2019222781B2 (en) | 2021-05-13 |
| ES2721922T3 (es) | 2019-08-06 |
| CA2908365C (en) | 2023-02-28 |
| EP3003292B1 (en) | 2019-03-20 |
| WO2014187945A1 (en) | 2014-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX391850B (es) | Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington | |
| MX2022005290A (es) | Compuestos heterociclicos como inmunomoduladores. | |
| EA201891203A1 (ru) | Гетероциклические соединения в качестве иммуномодуляторов | |
| PH12017501306A1 (en) | Inhibitors of histone demethylases | |
| MX389242B (es) | Compuestos para su uso en el tratamiento de trastornos neuromusculares | |
| BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
| WO2017059385A8 (en) | 11,13-modified saxitoxins for the treatment of pain | |
| WO2015015378A3 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
| WO2016004404A3 (en) | Gls1 inhibitors for treating disease | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
| BR112015028516A2 (pt) | tratamento ou prevenção de distúrbios neurodegenerativos com o uso de mentol, linalol e/ou icilina | |
| MX2017010422A (es) | Imidazolil enonas triciclicas como moduladores de inflamacion antioxidantes. | |
| BR112016016098A2 (pt) | Compostos orgânicos | |
| MX375924B (es) | Moduladores de proteinas del choque termico 70 (hsp70) y metodos para fabricar y usar el mismo. | |
| BR112015006063A2 (pt) | compostos heteroaromáticos, processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica | |
| BR112015026484A2 (pt) | tratamento ou prevenção de dano neuronal não inflamatório de trauma cerebral e acidentes vasculares cerebrais usando mentol, linalool e/ou icilin | |
| WO2015044961A3 (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide | |
| BR112015007095A8 (pt) | derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados, composição farmacêutica compreendendoos e uso dos referidos derivados | |
| BR112015028884A2 (pt) | tratamento ou prevenção de depressão utilizando mentol e/ou icilina | |
| EA201401142A1 (ru) | Замещенные 6-аминоникотинамиды, несущие он-содержащую группу, в качестве модуляторов kcnq2/3 | |
| BR112015026533A2 (pt) | tratamento ou prevenção das desordens do autismo com o uso de mentol, linalol e/ou icilina | |
| BR112016006582A2 (pt) | terapia combinada laquinimod para o tratamento da esclerose múltipla | |
| WO2014172453A3 (en) | Novel compositions useful in treating brain-related diseases or disorders and methods using same | |
| BR112019002799A8 (pt) | Composto, composição farmacêutica, método para tratar um indivíduo tendo uma doença neurodegenerativa, método para tratar um indivíduo tendo a doença de alzheimer e método para tratar um indivíduo tendo uma doença ou condição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH) |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |